ASSESSING THE POTENTIAL VALUE OF AN INNOVATIVE ONCOLOGY THERAPY FROM THE HEALTH TECHNOLOGY ASSESSMENT (HTA) PERSPECTIVE: MARRYING CLINICAL VALUE FRAMEWORKS WITH ECONOMIC ASSESSMENT METHODOLOGY

被引：0
|
作者：
Zheng, Y. [1 ]
Lanitis, T. [2 ]
Ambavane, A. [2 ]
Proskorovsky, I [3 ]
Bharmal, M. [4 ]
Phatak, H. [1 ]
机构：
[1] EMD Serono Inc, Rockland, MA USA
[2] Evidera, London, England
[3] Evidera, St Laurent, PQ, Canada
[4] Merck KGaA, Darmstadt, Germany
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.09.108
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN26
引用
收藏
页码：S19 / S19
页数：1
相关论文
共 50 条
  • [31] Prioritizing investments in health technology assessment -: Can we assess potential value for money?
    Davies, L
    Drummond, M
    Papanikolaou, P
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2000, 16 (01) : 73 - 91
  • [32] ASSESSING THE VALUE OF NOVEL IMMUNO-ONCOLOGY (I-O) THERAPIES: HOW CONSISTENT IS THE HEALTH TECHNOLOGY ASSESSMENT (HTA) BODIES' CONSIDERATION OF THE SURVIVAL BENEFIT IN THE ABSENCE OF LONG-TERM DATA?
    Jonsson, B.
    Chao, D.
    Toumi, M.
    Child, A.
    Morris, J.
    Hertel, N.
    VALUE IN HEALTH, 2018, 21 : S65 - S66
  • [33] DOES THE TREND TOWARDS VALUE FRAMEWORKS REQUIRE NEW APPROACHES TO EVIDENCE DEVELOPMENT AND HEALTH TECHNOLOGY ASSESSMENT?
    Teale, C. W.
    Entwistle, J.
    Freeman, S.
    VALUE IN HEALTH, 2016, 19 (07) : A763 - A763
  • [34] Advanced therapy medicinal products: value judgement and ethical evaluation in health technology assessment
    Elisabete Gonçalves
    The European Journal of Health Economics, 2020, 21 : 311 - 320
  • [35] Advanced therapy medicinal products: value judgement and ethical evaluation in health technology assessment
    Goncalves, Elisabete
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2020, 21 (03): : 311 - 320
  • [36] A SYSTEMATIC REVIEW OF PRODUCTIVITY GAIN/LOSS IN HEALTH ECONOMIC EVALUATIONS: AN ELEMENT FOR VALUE ASSESSMENT OF INNOVATIVE TREATMENTS
    Mamiya, H.
    Wattanakamolkul, K.
    Li, N.
    Wu, D. B. C.
    Yoneyama-Hirozane, M.
    Igarashi, A.
    VALUE IN HEALTH, 2024, 27 (12)
  • [37] A systematic review of the early dialogue frameworks used within health technology assessment and their actual adoption from HTA agencies
    Ibargoyen-Roteta, Nora
    Galnares-Cordero, Lorea
    Benguria-Arrate, Gaizka
    Rocio Chacon-Acevedo, Kelly
    Paula Gutierrez-Sepulveda, Maria
    Low-Padilla, Eduardo
    Herbert De La Hoz-Siegler, Ilich
    Isabel Guevara-Perez, Claudia
    del Pozo-Perez, Angel
    Suarez, Marta
    Dauben, Hans Peter
    Otte, Maximilian
    Gutierrez-Ibarluzea, Inaki
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [38] Obtaining value for money from pharmaceuticals:: Reference pricing or health technology assessment?
    Drummod, M. F.
    Joensson, B.
    Rutten, F.
    Stargardt, T.
    VALUE IN HEALTH, 2007, 10 (06) : A370 - A370
  • [39] Medication reconciliation process: Assessing value, adoption, and the potential of information technology from pharmacists' perspective
    Al Anazi, Abdullah
    HEALTH INFORMATICS JOURNAL, 2021, 27 (01)
  • [40] Threats to the Value of Health Technology Assessment: Qualitative Evidence From Canada and Poland
    Wranik, Wieslawa Dominika
    Gambold, Liesl
    Zielinska, Dorota
    Sevgur, Serperi
    INTERNATIONAL JOURNAL OF QUALITATIVE METHODS, 2019, 18
12345